undefined undefined
NaN.000
NaN.00%
Torm A/S (DK:TRMD.A) has released an update. Torm A/S reports a robust first qu...
05-10 05:28
VANCOUVER, BC, May 2, 2024 /PRNewswire/ - Sandstorm Gold Ltd. ("Sandstorm Gold Royalties", "Sandstorm" or the "Company") (NYSE: SAND) (TSX: SSL) has released its financial results for the fi...
05-03 05:02
Losers: Marinus Pharmaceuticals (MRNS) -74% provides update on the phase 3 RAISE trial and reports preliminary first Quarter 2024 financial results. NextPlat Corp (NXPL) -19%. Neumora Therapeutics (NM...
04-15 20:21
Torm A/S (DK:TRMD.A) has released an update. TORM A/S successfully passed all r...
04-12 05:27
Conference call planned for early April 2024 to provide update on NurOwn program NEW YORK, April 1, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer...
04-01 20:05
VANCOUVER, BC, March 28, 2024 /PRNewswire/ - Sandstorm Gold Ltd. ("Sandstorm Gold Royalties", "Sandstorm" or the "Company") (NYSE: SAND) (TSX: SSL) is pleased to announce that its Board of D...
03-28 20:34
Torm A/S (DK:TRMD.A) has released an update. TORM plc has announced a capital i...
03-27 18:20
Torm A/S (DK:TRMD.A) has released an update. TORM A/S, a leading carrier of ref...
03-23 04:27
VANCOUVER, BC, March 18, 2024 /PRNewswire/ - Sandstorm Gold Ltd. ("Sandstorm Gold Royalties", "Sandstorm" or the "Company") (NYSE: SAND) (TSX: SSL) is pleased to provide updates on various d...
03-18 20:15
Evercore ISI Group analyst Jonathan Chappell maintains TORM (NASDAQ:TRMD) with a Outperform and raises the price target from $42 to $44.
03-08 23:25